梅斯医学

订阅

MedSci主页 / 所有栏目 / 梅斯医学

阿吉安基因完成近2亿元首轮融资，凯乘资本担任财务顾问：

2021-12-08 网络 网络

关注

阿吉安基因完成近2亿元首轮融资，凯乘资本担任财务顾问

近日，阿吉安基因宣布完成近2亿元首轮融资。本轮融资由天士力资本旗下渤溢基金领投，华西基金、劲邦资本、新投投资、海鼎资本、海峡创投等专业投资机构、政府基金以及实力卓著的国企联合跟投。WinX Capital 凯乘资本担任财务顾问。优秀投资机构的加入，使阿吉安基因可以在技术研发及市场开拓等方面加快推进。

阿吉安基因，作为感染精准诊疗一体化解决方案的领导者，以其mNGS+PCR等多平台优势和核心技术，特别是强大的生信分析系统和临床医学报告能力，形成了阳性检出率高出行业平均水平10个百分点的优质检测水平，以及快速反应效率和良好的临床服务口碑。

上市公司孵化，团队综合实力独树一帜
特别的是，阿吉安基因是由上市药企广生堂药业（证券代码300436）孵化的生物医学国家级高新技术企业。广生堂是一家深耕抗病毒领域20余年的企业，在感染精准诊疗领域给予了阿吉安强大的渠道和专家资源助力，上市公司培育发展的优秀经验和规范化经营理念扎根于阿吉安基因的成长基因中，以实业报国为初心，在企业快速发展的同时，追求经营的平衡性，回报股东、回报社会。
阿吉安基因的亮眼之处，还在于团队的综合实力在业内可谓独树一帜。公司齐聚了海外归国科学家、基因行业内顶级精英，公司创始人具备丰富的生物企业管理经验，并担纲国家重点生物技术产业项目及国内顶级学术机构，形成战略发展、技术研发、生信医学、临床市场、全国营销布局、经营管理等各维度全方位格局的高效能团队合力，使得阿吉安以前瞻性的视野、优秀的研发能力、敏锐的市场洞察力、独特的市场定位和高效的内部管理，自2020年起呈爆发式增长，成为行业内增长斜率最高、实现效益最佳的一匹黑马。
 
多技术感染分子诊断综合平台，全面满足临床需求
阿吉安基因自成立以来即不断进行自主研发，现已开发出基于二代基因测序的PathoSeq™ 平台，针对不明原因病原体感染，可快速全面检出2万余种病原微生物，阳性检出率高；基于荧光定量PCR技术的SuperSens平台针对临床常见感染，具有时效性强、灵敏度高等优势。多技术感染分子诊断综合平台针对不同情况，提供快速、便捷、分层解决方案，全面满足临床需求。目前，阿吉安基因在福州、北京、上海、郑州、武汉、广州、重庆等多地建有医学检验实验室、研发中心和生产基地，总面积近30000平方米。本轮融资资金阿吉安将用于新技术的研发升级及市场规模进一步提升。
领投方渤溢基金总经理朱艳飞表示：“选择阿吉安，一方面是认可行业赛道的选择，感染性疾病已经成为全球致死率最高的疾病种类之一，传统诊断方法的时效性、特异度、灵敏度均不足以满足临床需求，病原微生物等高新生物技术能够有效解决临床痛点，市场潜力巨大。另一方面，我们非常看好阿吉安团队的综合实力，团队拥有战略性的发展眼光，在解决问题方面能力非常优异，市场定位具备差异化优势，综合因素使得其发展速度和发展斜率表现突出。我们相信有了资本的加持，阿吉安能够走得更快更远。”
秉念如初，未来可期。插上资本的翅膀，厚积薄发的阿吉安基因必将成为高科技生物检测领域独有的一道风景。

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719325, encodeId=d5501e19325d2, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Jul 22 04:11:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459150, encodeId=fb6a145915087, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Fri Dec 10 09:11:32 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078375, encodeId=87dc10e837591, content=非常有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b586392837, createdName=ms2000001702002797, createdTime=Thu Dec 09 10:19:38 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078335, encodeId=0f1210e833515, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Thu Dec 09 08:57:14 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078318, encodeId=9c5910e8318a7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a5343088, createdName=ms5000000833449414, createdTime=Thu Dec 09 08:41:01 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244245, encodeId=7de81244245e4, content=又是钱！医学研发需要投资呀，赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Dec 08 21:11:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2022-07-22 kord1993

    #资本#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1719325, encodeId=d5501e19325d2, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Jul 22 04:11:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459150, encodeId=fb6a145915087, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Fri Dec 10 09:11:32 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078375, encodeId=87dc10e837591, content=非常有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b586392837, createdName=ms2000001702002797, createdTime=Thu Dec 09 10:19:38 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078335, encodeId=0f1210e833515, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Thu Dec 09 08:57:14 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078318, encodeId=9c5910e8318a7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a5343088, createdName=ms5000000833449414, createdTime=Thu Dec 09 08:41:01 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244245, encodeId=7de81244245e4, content=又是钱！医学研发需要投资呀，赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Dec 08 21:11:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-10 zhao4618

    #融资#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1719325, encodeId=d5501e19325d2, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Jul 22 04:11:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459150, encodeId=fb6a145915087, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Fri Dec 10 09:11:32 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078375, encodeId=87dc10e837591, content=非常有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b586392837, createdName=ms2000001702002797, createdTime=Thu Dec 09 10:19:38 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078335, encodeId=0f1210e833515, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Thu Dec 09 08:57:14 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078318, encodeId=9c5910e8318a7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a5343088, createdName=ms5000000833449414, createdTime=Thu Dec 09 08:41:01 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244245, encodeId=7de81244245e4, content=又是钱！医学研发需要投资呀，赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Dec 08 21:11:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-09 ms2000001702002797

    非常有意义

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1719325, encodeId=d5501e19325d2, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Jul 22 04:11:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459150, encodeId=fb6a145915087, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Fri Dec 10 09:11:32 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078375, encodeId=87dc10e837591, content=非常有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b586392837, createdName=ms2000001702002797, createdTime=Thu Dec 09 10:19:38 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078335, encodeId=0f1210e833515, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Thu Dec 09 08:57:14 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078318, encodeId=9c5910e8318a7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a5343088, createdName=ms5000000833449414, createdTime=Thu Dec 09 08:41:01 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244245, encodeId=7de81244245e4, content=又是钱！医学研发需要投资呀，赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Dec 08 21:11:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-09 药师小王

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1719325, encodeId=d5501e19325d2, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Jul 22 04:11:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459150, encodeId=fb6a145915087, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Fri Dec 10 09:11:32 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078375, encodeId=87dc10e837591, content=非常有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b586392837, createdName=ms2000001702002797, createdTime=Thu Dec 09 10:19:38 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078335, encodeId=0f1210e833515, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Thu Dec 09 08:57:14 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078318, encodeId=9c5910e8318a7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a5343088, createdName=ms5000000833449414, createdTime=Thu Dec 09 08:41:01 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244245, encodeId=7de81244245e4, content=又是钱！医学研发需要投资呀，赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Dec 08 21:11:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-09 ms5000000833449414

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1719325, encodeId=d5501e19325d2, content=<a href='/topic/show?id=12b792553da' target=_blank style='color:#2F92EE;'>#资本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92553, encryptionId=12b792553da, topicName=资本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef5032698226, createdName=kord1993, createdTime=Fri Jul 22 04:11:32 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1459150, encodeId=fb6a145915087, content=<a href='/topic/show?id=c2258886959' target=_blank style='color:#2F92EE;'>#融资#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88869, encryptionId=c2258886959, topicName=融资)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61b96121455, createdName=zhao4618, createdTime=Fri Dec 10 09:11:32 CST 2021, time=2021-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078375, encodeId=87dc10e837591, content=非常有意义, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b586392837, createdName=ms2000001702002797, createdTime=Thu Dec 09 10:19:38 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078335, encodeId=0f1210e833515, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Thu Dec 09 08:57:14 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078318, encodeId=9c5910e8318a7, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90a5343088, createdName=ms5000000833449414, createdTime=Thu Dec 09 08:41:01 CST 2021, time=2021-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1244245, encodeId=7de81244245e4, content=又是钱！医学研发需要投资呀，赞！, beContent=null, objectType=article, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Dec 08 21:11:32 CST 2021, time=2021-12-08, status=1, ipAttribution=)]
    2021-12-08 CHANGE

    又是钱！医学研发需要投资呀，赞！

    0